This poster is published under an
open license. Please read the
disclaimer for further details.
Type:
Educational Exhibit
Keywords:
Lymphoma, Imaging sequences, MR-Spectroscopy, MR, CT, Oncology, Neuroradiology brain, CNS
Authors:
A. Brakus, K. Petrovic, N. Vuckovic, S. Stojanovic, J. Ostojic; Novi Sad/RS
DOI:
10.1594/ecr2015/C-2577
References
1.
Baraniskin A,
,Deckert M,
Schulte-Altedorneburg G,
Schlegel U,
Schroers R.
Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Brit J Haematol.
2012 Feb; 56(4):421–32.
2.
Rubenstein J.L et al.
Gene expression and angiotropism in primary CNS lymphoma BLOOD 2006 May 107(9):3716-3723.
3.
Commins D.L.
Pathology of Primary Central Nervous System Lymphoma .
Neurosurg Focus.
2006 Nov;21(5):1-10
4.
Reiche W,
Hagen T,
Schuchardt V,
Billmann P.
Diffusion-weighted MR imaging improves diagnosis of CNS lymphomas.
Clinical Neurol and Neurosur.
2007 Jan;109(1):93-101.
5.
Kim HS,
Jahng GH,
Ryu CW,
et al.
Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study.
AJNR 2009; 30: 1574–7
6.
Clinical MR Neuroimaging Diffusion,
Perfusion and Spectroscopy.
Gillard J.
H.,
Waldma A,
Barker B.P,
Cambridge University Press,
2004,
Chapter 19.MR spectroscopy of brain tumors in adults; p 317.
7.
Bourekas E,
Varakis K,
Bruns D,
Christoforidis GA,
Baujan M,
Slone HW,
Kehagias D.
Lesions of the corpus callosum: MR imaging and differential considerations in adults and children.
AJR.
2002 Jul;179(1):251-7.